5/2012
vol. 16
Original paper
Atypical dissemination of lung cancer to the adrenal gland and to the spleen
Katarzyna Fedyszyn-Urbanowicz
,
Grażyna Bierzyńska-Macyszyn
,
Wspolczesna Onkol 2012; 16 (5): 444–446
Online publish date: 2012/11/20
Get citation
PlumX metrics:
IntroductionMetastases to organs such as the liver, bones or central nervous system appear to be a frequent complication of lung cancer, whereas metastases to the suprarenal glands are found less frequently [1]. Metastases of lung cancer to the spleen are a great rarity and they are described sporadically [2].
An adrenal gland tumor detected incidentally during imaging tests is described as an incidentaloma [3–7].
Splenic lesions are most often incidentally detected on imaging tests requested for other conditions. Primary spleen tumors are extremely rare [8]. Primary cysts acquiring enormous proportions and hemangiomas are classified as benign tumors [9, 10]. Metastatic lesions and inflammatory pseudotumors may also be seen, but only very rarely and usually as casuistry [11, 12]. Splenic lesions may be observed in the course of malignant lymphoma [13, 14]. Lesions characteristic of sclerosing angiomatoid nodular transformation (SANT) have also been described [15].
In most cases, the typical characteristics of splenic tumors are established on the basis of histopathological findings, which are obtained by the surgical removal of the tumor or by post-mortem examination [8, 10, 16–18].
Metastases to the adrenal gland are also rare. This work presents a case of simultaneous dissemination of lung cancer to the adrenal gland and to the spleen.Material and methodsA female patient (age 74) was sent from a hospital in Zawiercie for further investigations and management of a left lung tumor lesion discovered during X-ray examination. Chest surgeons had rejected her from an invasive therapy. However, bronchoscopy was performed and revealed no evidence of pathological bronchial lesions. In this situation the patient was sent to our hospital for the purpose of making the histopathological diagnosis (History No. 16735/877/09).
Computed tomography (CT) scan showed chest infiltration situated peripherally in the left lung. After establishing the distance, place and depth of the puncture by using CT (Fig. 1), the parietal tumor was visualized by ultrasound and a biopsy was performed. We performed an ultrasound-guided (free hand technique) fine-needle biopsy of the lesion using a Hitachi EUS 515 sonographic machine (Fig. 2). The procedure was performed under local anesthesia; no complications were recorded.
The ultrasound examination of the abdomen revealed a pathological mass in the spleen and in the left adrenal gland (Fig. 3). We also performed in local anesthesia an ultrasound-guided (free hand technique) fine-needle biopsy of these lesions.Results and discussionIn our case small cell lung cancer was detected in the percutaneous biopsy of the left lung. The same type of cancer as in the left lung was observed in both the adrenal gland and in the spleen (metastases of small cell cancer).
Imaging methods available to us showed no evidence of cancer metastases in other organs.
In the existing literature, we found only a few cases of lung cancer metastases to the spleen [2, 17, 18]. There are also some descriptions of metastases isolated in spleen from other organs [16]. Simultaneous metastases of lung cancer to the adrenal gland and the spleen have never been described.
The case presented above shows that the metastatic lesion can sometimes be an accessible place to collect tissue for diagnosing the cancer pattern of the primary cancer site. The case is exceptional because the spleen is an organ where lung cancer metastases are not frequently found, while metastases to the adrenal gland alone are common. More often, metastases are observed in the liver. The case is also unique because the adrenal gland and the spleen are organs where finding concurrent metastases of lung cancer is very rare.
The patient received combined chemoradiotherapy. She was closely monitored over an 18-month observation period following treatment. No new metastases were reported.
The authors declare no conflict of interest.References 1. Bilimoria KY, Shen WT, Elaraj D, Bentrem DJ, Winchester DJ, Kebebew E, Sturgeon C. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 2008; 113: 3130-6.
2. Van Hul I, Cools P, Rutsaert R. Solitary splenic metastasis of an adenocarcinoma of the lung 2 years postoperatively. Acta Chir Belg 2008; 108: 462-3.
3. Al-Hawary MM, Francis IR, Korobkin M. Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Best Pract Res Clin Endocrinol Metab 2005; 19: 277-92.
4. Hennings J, Hellman P, Ahlström H, Sundin A. Computed tomography, magnetic resonance imaging, and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas. Eur J Radiol 2009; 69: 314-23.
5. Johnson PT, Horton KM, Fishman EK. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics 2009; 29: 1333-51.
6. Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinical inapparent adrenal mass (“incidentaloma”). Ann Intern Med 2003; 138: 424-9.
7. Terzolo M, Bovio S, Pia A, Reimondo G, Angeli A. Management of adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 2009; 23: 233-43.
8. Kochar K, Vijayasekar C, Pandey U, Bhogal R, Brown L, Mathew G. Primary carcinosarcoma of spleen: case report of a rare tumor and review of the literature. Int J Surg Pathol 2009; 17: 72-7.
9. Lee H, Maeda K. Hamartoma of the spleen. Arch Pathol Lab Med 2009; 133: 147-51.
10. Orawczyk T, Ćwik P, Ziaja D, Kazibudzki M. Familia lymphangioma – a rare form of splenic cysts. Chir Pol 2002; 4: 187-91.
11. Bhatt S, Simon R, Dogra VS. Radiologic-pathologic conferences of the University of Rochester School of Medicine: inflammatory pseudotumors of the spleen. AJR Am J Roentgenol 2008; 191: 1477-9.
12. Tee M, Vos P, Zetler P, Wiseman SM. Incidental littoral cell angioma of the spleen. World J Surg Oncol 2008; 6: 87-92.
13. Gupta R, Naseem S, Sukumaran S, Kashyap R, Kaur S, Paul L. Splenic lymphoma with villous lymphocytes. Indian J Pathol Microbiol 2008; 51: 113-5.
14. Takata F, Kaida H, Ishibashi M, et al. Primary splenic lymphoma detected by F-18 FDG PET. Clin Nucl Med 2008; 33: 204-7.
15. Koreishi AF, Saenz AJ, Fleming SE, Teruya-Feldstein J. Sclerosing angiomatoid nodular transformation (SANT) of the spleen: a report of 3 cases. Int J Surg Pathol 2010; 18: S136-41.
16. Showalter SL, Hager E, Yeo CJ. Metastatic disease to the pancreas and spleen. Semin Oncol 2008; 35: 160-71.
17. Kinoshita A, Nakano M, Fukuda M, et al. Splenic metastasis from lung cancer. Neth J Med 1995; 47: 219-23.
18. Dias AR, Pinto RA, Ravanini JN, Lupinacci RM, Cecconello I, Ribeiro U Jr. Isolated splenic metastasis from lung squamous cell carcinoma. World J Surg Oncol 2012; 10: 24.
Address for correspondence
Marek Chorąży MD, PhD
Department of Clinical Oncology and Internal Medicine
S. Leszczyński Hospital
Raciborska 27
40-074 Katowice, Poland
tel. +48 601 51 38 87
fax +48 32 251 45 33
e-mail: marekchorazy@wp.pl
Submitted: 13.10.2011
Accepted: 12.09.2012
Copyright: © 2012 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License ( http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
|
|